These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2431196)

  • 1. On haemodilution therapy for patients with sudden loss of hearing: clinical and rheological results.
    Wilhelm HJ; Jung F; Kiesewetter H; Recktenwald C
    Klin Wochenschr; 1986 Oct; 64(20):1058-61. PubMed ID: 2431196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheological therapeutic effects in diseases of the inner ear].
    Hörmann K; Bernal Sprekelsen M
    An Otorrinolaringol Ibero Am; 1990; 17(4):397-404. PubMed ID: 1699442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].
    Kiesewetter H; Jung F; Blume J; Bulling B; Franke RP
    Klin Wochenschr; 1986 Jan; 64(1):29-37. PubMed ID: 2419635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks].
    Haass A; Kroemer H; Jäger H; Müller K; Decker I; Wagner EM; Schimrigk K
    Dtsch Med Wochenschr; 1986 Oct; 111(44):1681-6. PubMed ID: 2429818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rheologic problems of microcirculation and consequences of drug therapy for sudden deafness].
    Klemm E; Altmann E; Lange O
    Laryngol Rhinol Otol (Stuttg); 1983 Feb; 62(2):62-4. PubMed ID: 6843234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodilution therapy of acute inner ear damage].
    Pilgramm M
    Acta Med Austriaca; 1991; 18 Suppl 1():60-2. PubMed ID: 1719734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low-molecular-weight hydroxyethyl starch or low-molecular-weight dextran in acute inner ear disorders? A randomized comparative study].
    Pilgramm M; Vestner HJ; Schumann K
    Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):377-80. PubMed ID: 2427904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low molecular weight dextrans (Rheomacrodex) in the therapy of inner ear hearing loss].
    Erlach A; Rinke E
    Wien Med Wochenschr; 1986 Sep; 136(18):473-6. PubMed ID: 2432732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolytic therapy in sudden deafness with recombinant tissue-type plasminogen activator. Hemorheologic and therapeutic effects].
    Hagen R
    Laryngorhinootologie; 1991 Jul; 70(7):353-8. PubMed ID: 1910364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte solution over 48 hours].
    Brehme S; Keysser G; Turowski A; Schmidt HH
    Z Gesamte Inn Med; 1993 Oct; 48(10):506-10. PubMed ID: 7504854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Organ blood supply and oxygenation during limited isovolemic hemodilution with 6% HES 200/0.62 and 6% Dextran 70].
    Brückner UB; Messmer K
    Anaesthesist; 1991 Aug; 40(8):434-40. PubMed ID: 1719841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in coagulation physiology and rheology after preoperative normovolemic hemodilution].
    Hensel M; Wrobel R; Volk T; Pahlig H; Kox WJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):481-7. PubMed ID: 9019177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
    Scheffler P; Jung F; Mrowietz C; Waldhausen P; Leipnitz G; Häuser B
    Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodilution].
    Landgraf H
    Wien Med Wochenschr; 1986; 136 Spec No():36-40. PubMed ID: 3548090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypercholesteremia and hyperfibrinogenemia in sudden deafness].
    Suckfüll M; Thiery J; Wimmer C; Mees K; Schorn K
    Laryngorhinootologie; 1997 Aug; 76(8):453-7. PubMed ID: 9376027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conjunctival microcirculation and hemorheology in patients with venous occlusions of the retina].
    Arend O; Wolf S; Schulte K; Jung F; Bertram B; Reim M
    Fortschr Ophthalmol; 1991; 88(3):243-7. PubMed ID: 1889771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why treat sudden hearing loss.
    Wilson WR
    Am J Otol; 1984 Oct; 5(6):481-3. PubMed ID: 6083727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheopheresis for sudden sensorineural hearing loss.
    Klingel R; Heibges A; Uygun-Kiehne S; Fassbender C; Mösges R
    Atheroscler Suppl; 2009 Dec; 10(5):102-6. PubMed ID: 20129385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sudden hearing loss in 1997: etiopathogenic hypothesis, management, prognostic factors and treatment].
    Mosnier I; Bouccara D; Sterkers O
    Ann Otolaryngol Chir Cervicofac; 1997; 114(7-8):251-66. PubMed ID: 9686012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.